The presymptomatic stages of frontotemporal dementia (FTD) are still poorly defined and encompass a long accrual of progressive biological (preclinical) and then clinical (prodromal) changes, antedating the onset of dementia. The heterogeneity of clinical presentations and the different neuropathological phenotypes have prevented a prior clear description of either preclinical or prodromal FTD. Recent advances in therapeutic approaches, at least in monogenic disease, demand a proper definition of these predementia stages. It has become clear that a consensus lexicon is needed to comprehensively describe the stages that anticipate dementia. The goal of the present work is to review existing literature on the preclinical and prodromal phases of FTD, providing recommendations to address the unmet questions, therefore laying out a strategy for operationalizing and better characterizing these presymptomatic disease stages.

Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia / Benussi, A.; Alberici, A.; Samra, K.; Russell, L. L.; Greaves, C. V.; Bocchetta, M.; Ducharme, S.; Finger, E.; Fumagalli, G.; Galimberti, D.; Jiskoot, L. C.; Le Ber, I.; Masellis, M.; Nacmias, B.; Rowe, J. B.; Sanchez-Valle, R.; Seelaar, H.; Synofzik, M.; Rohrer, J. D.; Borroni, B.; Afonso, S.; Almeida, M. R.; Anderl-Straub, S.; Andersson, C.; Antonell, A.; Archetti, S.; Arighi, A.; Balasa, M.; Barandiaran, M.; Bargallo, N.; Bartha, R.; Bender, B.; Bertoux, M.; Bertrand, A.; Bessi, V.; Black, S.; Borrego-Ecija, S.; Bouzigues, A.; Bras, J.; Brice, A.; Bruffaerts, R.; Butler, C. R.; Camuzat, A.; Canada, M.; Cantoni, V.; Caroppo, P.; Cash, D.; Castelo-Branco, M.; Colliot, O.; Convery, R.; Cope, T.; Danek, A.; de Mendonca, A.; Deramecourt, V.; Di Fede, G.; Diez, A.; Duro, D.; Fenoglio, C.; Ferrari, C.; Ferreira, C. B.; Fox, N.; Freedman, M.; Funkiewiez, A.; Gabilondo, A.; Gauthier, S.; Gazzina, S.; Gerhard, A.; Giaccone, G.; Gorostidi, A.; Graff, C.; Guerreiro, R.; Heller, C.; Hoegen, T.; Indakoetxea, B.; Jelic, V.; Karnath, H. -O.; Keren, R.; Kuchcinski, G.; Laforce, R.; Waldo, M. L.; Langheinrich, T.; Lebouvier, T.; Leitao, M. J.; Levin, J.; Llado, A.; Lombardi, G.; Lombardi, J.; Loosli, S.; Maruta, C.; Mead, S.; Meeter, L.; Miltenberger, G.; van Minkelen, R.; Mitchell, S.; Moore, K.; Moreno, F.; Nelson, A.; Nicholas, J.; Oijerstedt, L.; Olives, J.; Otto, M.; Ourselin, S.; Panman, J.; Papma, J. M.; Pasquier, F.; Pijnenburg, Y.; Polito, C.; Premi, E.; Prioni, S.; Prix, C.; Rademakers, R.; Redaelli, V.; Rinaldi, D.; Rittman, T.; Rogaeva, E.; Rollin, A.; Rosa-Neto, P.; Rossi, G.; Rossor, M.; Santana, I.; Santiago, B.; Saracino, D.; Sayah, S.; Scarpini, E.; Schonecker, S.; Schroeter, M.; Shafei, R.; Shoesmith, C.; Sorbi, S.; Swift, I.; Tabuas-Pereira, M.; Tagliavini, F.; Tainta, M.; Taipa, R.; Tang-Wai, D.; Tartaglia, C.; Thomas, D. L.; Thompson, P.; Thonberg, H.; Timberlake, C.; Tiraboschi, P.; Todd, E.; Van Damme, P.; Vandenberghe, R.; Vandenbulcke, M.; van Swieten, J. C.; Veldsman, M.; Verdelho, A.; Villanua, J.; Warren, J.; Wilke, C.; Woollacott, I.; Wlasich, E.; Zetterberg, H.; Zulaica, M.. - In: ALZHEIMER'S & DEMENTIA. - ISSN 1552-5260. - 18:7(2022), pp. 1408-1423. [10.1002/alz.12485]

Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

Fumagalli G.;
2022-01-01

Abstract

The presymptomatic stages of frontotemporal dementia (FTD) are still poorly defined and encompass a long accrual of progressive biological (preclinical) and then clinical (prodromal) changes, antedating the onset of dementia. The heterogeneity of clinical presentations and the different neuropathological phenotypes have prevented a prior clear description of either preclinical or prodromal FTD. Recent advances in therapeutic approaches, at least in monogenic disease, demand a proper definition of these predementia stages. It has become clear that a consensus lexicon is needed to comprehensively describe the stages that anticipate dementia. The goal of the present work is to review existing literature on the preclinical and prodromal phases of FTD, providing recommendations to address the unmet questions, therefore laying out a strategy for operationalizing and better characterizing these presymptomatic disease stages.
2022
7
Benussi, A.; Alberici, A.; Samra, K.; Russell, L. L.; Greaves, C. V.; Bocchetta, M.; Ducharme, S.; Finger, E.; Fumagalli, G.; Galimberti, D.; Jiskoot,...espandi
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia / Benussi, A.; Alberici, A.; Samra, K.; Russell, L. L.; Greaves, C. V.; Bocchetta, M.; Ducharme, S.; Finger, E.; Fumagalli, G.; Galimberti, D.; Jiskoot, L. C.; Le Ber, I.; Masellis, M.; Nacmias, B.; Rowe, J. B.; Sanchez-Valle, R.; Seelaar, H.; Synofzik, M.; Rohrer, J. D.; Borroni, B.; Afonso, S.; Almeida, M. R.; Anderl-Straub, S.; Andersson, C.; Antonell, A.; Archetti, S.; Arighi, A.; Balasa, M.; Barandiaran, M.; Bargallo, N.; Bartha, R.; Bender, B.; Bertoux, M.; Bertrand, A.; Bessi, V.; Black, S.; Borrego-Ecija, S.; Bouzigues, A.; Bras, J.; Brice, A.; Bruffaerts, R.; Butler, C. R.; Camuzat, A.; Canada, M.; Cantoni, V.; Caroppo, P.; Cash, D.; Castelo-Branco, M.; Colliot, O.; Convery, R.; Cope, T.; Danek, A.; de Mendonca, A.; Deramecourt, V.; Di Fede, G.; Diez, A.; Duro, D.; Fenoglio, C.; Ferrari, C.; Ferreira, C. B.; Fox, N.; Freedman, M.; Funkiewiez, A.; Gabilondo, A.; Gauthier, S.; Gazzina, S.; Gerhard, A.; Giaccone, G.; Gorostidi, A.; Graff, C.; Guerreiro, R.; Heller, C.; Hoegen, T.; Indakoetxea, B.; Jelic, V.; Karnath, H. -O.; Keren, R.; Kuchcinski, G.; Laforce, R.; Waldo, M. L.; Langheinrich, T.; Lebouvier, T.; Leitao, M. J.; Levin, J.; Llado, A.; Lombardi, G.; Lombardi, J.; Loosli, S.; Maruta, C.; Mead, S.; Meeter, L.; Miltenberger, G.; van Minkelen, R.; Mitchell, S.; Moore, K.; Moreno, F.; Nelson, A.; Nicholas, J.; Oijerstedt, L.; Olives, J.; Otto, M.; Ourselin, S.; Panman, J.; Papma, J. M.; Pasquier, F.; Pijnenburg, Y.; Polito, C.; Premi, E.; Prioni, S.; Prix, C.; Rademakers, R.; Redaelli, V.; Rinaldi, D.; Rittman, T.; Rogaeva, E.; Rollin, A.; Rosa-Neto, P.; Rossi, G.; Rossor, M.; Santana, I.; Santiago, B.; Saracino, D.; Sayah, S.; Scarpini, E.; Schonecker, S.; Schroeter, M.; Shafei, R.; Shoesmith, C.; Sorbi, S.; Swift, I.; Tabuas-Pereira, M.; Tagliavini, F.; Tainta, M.; Taipa, R.; Tang-Wai, D.; Tartaglia, C.; Thomas, D. L.; Thompson, P.; Thonberg, H.; Timberlake, C.; Tiraboschi, P.; Todd, E.; Van Damme, P.; Vandenberghe, R.; Vandenbulcke, M.; van Swieten, J. C.; Veldsman, M.; Verdelho, A.; Villanua, J.; Warren, J.; Wilke, C.; Woollacott, I.; Wlasich, E.; Zetterberg, H.; Zulaica, M.. - In: ALZHEIMER'S & DEMENTIA. - ISSN 1552-5260. - 18:7(2022), pp. 1408-1423. [10.1002/alz.12485]
File in questo prodotto:
File Dimensione Formato  
2021 Benussi et al..pdf

accesso aperto

Descrizione: first online
Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 449.62 kB
Formato Adobe PDF
449.62 kB Adobe PDF Visualizza/Apri
Alzheimer s Dementia - 2021 - Benussi - Conceptual framework for the definition of preclinical and prodromal.pdf

accesso aperto

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 455.29 kB
Formato Adobe PDF
455.29 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/355690
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 25
social impact